- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Vertex Pharmaceuticals Inc+ Add to Watchlist
VRTX:US128.2900 USD 0.8900 0.70%
As of 20:10:00 ET on 05/29/2015.
Company Profile for Vertex Pharmaceuticals Inc (VRTX)
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company develops drugs for the treatment of cystic fibrosis, autoimmune diseases, cancer, inflammatory bowel disease, and neurological disorders.
Vertex Pharmaceuticals Inc
Key Executives for Vertex Pharmaceuticals Inc (VRTX)
|Jeffrey M Leiden "Jeff"President/CEO||Ian F SmithExec VP/CFO|
|Stuart A ArbuckleExec VP/Chief Commercial Ofcr||David AltshulerExec VP:Global Research|
|Jeffrey A Chodakewitz "Jeff"Exec VP:Global Medicines Dev||Amit K SachdevExec VP:Global Govt Strategy|
|Kenneth S BogerSenior VP/Secy/Gen Cnsl||Paul M SilvaSenior VP/Controller|
|Michael PartridgeVP:Investor Relations||Kelly LewisDirector:Investor Relations|